Kamada Ltd
NASDAQ:KMDA
| Market Cap (Intraday) | 277.74M |
| Current PE | 22.98 |
| Forward PE | 89.71 |
| 2yr Forward PE | 25.12 |
| 10-Day MA | $6.03 |
| 50-Day MA | $5.56 |
| 200-Day MA | $5.80 |
Kamada Ltd Stock, NASDAQ:KMDA
Science Park, 2 Holzman Street, Rehovot, HaMerkaz 7670402
Israel
Phone: +972.8.940.6472
Number of Employees: 408
Description
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the following segments: Proprietary Products and Distribution. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.